📘 Just published:
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
06.01.2026 14:59
👍 2
🔁 2
💬 0
📌 1
A very inspiring session indeed
27.09.2025 11:28
👍 1
🔁 0
💬 0
📌 0
It was such an honour for us to host this meeting in Copenhagen and to enjoy the company os more than 200 friends and colleagues
27.09.2025 11:27
👍 2
🔁 0
💬 0
📌 0
Excited to host - for the third time - this meeting of a scientific group that I joined in 1989, and which has since made a very substantial contribution to its field.
26.09.2025 06:55
👍 3
🔁 1
💬 0
📌 0
📅 Reminder: Registration is open for the @eortc.org #QualityofLife Group (QLG) autumn meeting, to be held on 25-26 September in Copenhagen!
⏰ Register by 19th August to secure your place!
🔗More info including on venue & programme: www.eortc.org/event/eortc-...
#QLGmeeting
22.07.2025 07:15
👍 4
🔁 3
💬 0
📌 0
Der er brug for handling
12.05.2025 19:13
👍 1
🔁 0
💬 0
📌 0
🚀 @eortc.org QLQ-C30 is the leading PRO measure in oncology! Since 2016, EORTC #QualityofLife Group strategy has evolved to stay ahead with cancer treatment advancements. 🌟This includes disease-specific modules, Computer Adaptive Testing (CAT), & Item Lists.
@mogensgroenvold.bsky.social #QoLConf25
12.05.2025 07:59
👍 4
🔁 2
💬 0
📌 0
🌐 The @eortc.org Item Library is an interactive platform for creating customised item lists, useful for novel treatments, early phase trials, rare disease groups & tailored clinical monitoring. 👏 Ongoing projects will expand adverse events coverage and HRQoL issues.
- C. Piccinin at #QoLConf25
12.05.2025 10:27
👍 2
🔁 1
💬 0
📌 0
🔍 The @eortc.org Computerised Adaptive Testing (CAT) is an innovative, individually responsive HRQoL measurement. CAT optimises item presentation based on prior responses, allowing for more precision and reduced response burden compared to conventional PRO questionnaires.
- H. Vachon #QoLConf25
12.05.2025 10:44
👍 3
🔁 1
💬 0
📌 0
📝The @eortc.org Write-In-Three Symptoms/Problems (WISP) instrument enables open-ended reporting of PROs, filling a crucial gap in capturing missing symptoms across various oncological settings. WISP is both acceptable and useful for patients.🌟
- C. Piccinin #QoLConf25
#CancerResearch #QualityofLife
12.05.2025 11:18
👍 3
🔁 1
💬 0
📌 0
Beretning om ventetid til specialiseret lindring for patienter med livstruende sygdomme
Beretning nr. 17/2024
Skarp kritik igen: På fem år er der ikke sket nævneværdige forbedringer af ventetiden til specialiseret lindring for patienter med livstruende sygdomme. Som samfund skal DK altså tage bedre hånd om mennesker med livstruende sygdomme #dkpol #sundpol www.rigsrevisionen.dk/revisionssag...
12.05.2025 13:14
👍 7
🔁 1
💬 1
📌 1
🔗 Often, the ‘integration of oncology & palliative care ideal’ is not a reality. The Joint Action Network of Expertise ‘JANE’ aims to bridge this gap by studying the timely integration of evidence-based palliative care into standard oncology care 🌟
@mogensgroenvold.bsky.social @eortc.org #QoLConf25
12.05.2025 14:19
👍 3
🔁 1
💬 0
📌 0
🔚 SESSION 4 focused on PROs for special cancer patient populations
Speakers: David Riedl, Anne-Sophie Darlington, Jaap Reijneveld, Paolo Bossi & Mogens Groenvold
Chairs: Dagmara Kuliś & @mogensgroenvold.bsky.social
#QoLConf25 #CancerResearch
12.05.2025 14:22
👍 2
🔁 2
💬 0
📌 0
Extremely happy to see the publication of our paper describing the gradual refinement and expansion of the EORTC QLG strategy through the last decade.
Thank you to all involved for both the excellent collaboration and the courage to make significant changes.
23.04.2025 10:12
👍 1
🔁 1
💬 0
📌 0
🤝As the clinical trial landscape evolves, so must our strategies for measuring patients’ #QualityofLife to ensure their voice is incorporated in the decision-making process
🔎Takeaways from new article in @thelancetoncol.bsky.social: www.eortc.org/blog/2025/04...
#GivingVoice2Patients @ema.europa.eu
15.04.2025 16:27
👍 6
🔁 3
💬 0
📌 0
Meget fint resume - jeg har virkelig været opløftet over at have taget samme skridt og at at finde et bedre sted. Det var desuden en lettelse at slette min tidligere Twitterprofil, som jeg ellers har haft stor glæde af
22.11.2024 13:04
👍 0
🔁 0
💬 0
📌 0